Zobrazeno 1 - 10
of 201
pro vyhledávání: '"H. Sörensen"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Niklas Hedin, Jovice B.S. Ng, Hjalmar Brismar, Lennart Bergström, Malin H. Sörensen, Padideh Kamali-Zare
Publikováno v:
Langmuir. 26:466-470
The transport of oligomeric molecules in silica spheres with cylindrical mesopores has been quantified and related to the structural features of the spherical particles and the interactions at the solid-liquid interface. An emulsion-solvent evaporati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afac41a7c4a0296d39f9a28c7ac81d65
https://doi.org/10.1021/la902092e
https://doi.org/10.1021/la902092e
Autor:
H. Sattler, G.-R. Burmester, H. Sörensen, Herbert Kellner, Wolfgang Hartung, J. Strunk, T. M. Backhaus, J. Kaufmann, Wolfgang A. Schmidt, Marina Backhaus, Katinka Albrecht, Karsten Becker, L. Meier, Sarah Ohrndorf
Publikováno v:
Arthritis & Rheumatism. 61:1194-1201
Objective To introduce a new standardized ultrasound score based on 7 joints of the clinically dominant hand and foot (German US7 score) implemented in daily rheumatologic practice. Methods The ultrasound score included the following joints of the cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65132454c4a09395f66d3712da327223
https://doi.org/10.1002/art.24646
https://doi.org/10.1002/art.24646
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 95:271-274
The vitamin D endocrine system, besides its traditional role in mineral metabolism, also affects the immune system. A recent study demonstrated that vitamin D supplementation restored a blunted delayed hypersensitivity response (DH) in elderly vitami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::383a10439d6e7f0c9889abfd69f559eb
https://doi.org/10.1055/s-0029-1210964
https://doi.org/10.1055/s-0029-1210964
Autor:
Matthias Schneider, G.-R. Burmester, Jürgen Braun, J. Sieper, J. Brandt, Xenofon Baraliakos, Joachim Listing, A. Zink, H Sörensen, Rieke Alten, Herbert Kellner, Henning Zeidler, Erika Gromnica-Ihle
Publikováno v:
Rheumatology. 44:670-676
Objective. Infliximab, a monoclonal antibody against tumour necrosis factor a (TNF-a), is approved in Europe for the treatment of patients with active ankylosing spondylitis (AS) who have responded inadequately to conventional therapy. This report pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b0431be6dc558e2be70418bf7bebcb8
https://doi.org/10.1093/rheumatology/keh584
https://doi.org/10.1093/rheumatology/keh584
Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis
Autor:
G.-R. Burmester, H Sörensen, A. Zink, J. Sieper, Matthias F. Schneider, Joachim Listing, E Gromnica-Ihle, Jürgen Braun, J Brandt, Herbert Kellner, Rieke Alten, Henning Zeidler
Publikováno v:
Annals of the Rheumatic Diseases. 64:229-234
Objective: To obtain results of the second year extension of an original 3 month randomised, placebo controlled trial (and the 1 year extension study) assessing the use of infliximab, a monoclonal antibody to tumour necrosis factor α, for the treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2731f70e8beb035d4e9279d01959ac7
https://doi.org/10.1136/ard.2004.025130
https://doi.org/10.1136/ard.2004.025130
Autor:
J. Sieper, A Schwebig, H Sörensen, J. Brandt, M. Rudwaleit, Joachim Listing, Hildrun Haibel, Jürgen Braun
Publikováno v:
Rheumatology. 44:342-348
Objectives Treatment of ankylosing spondylitis (AS) with the tumour necrosis factor alpha (TNF-alpha) receptor fusion protein etanercept has shown efficacy in patients with active disease in randomized controlled trials (RCTs) for limited periods. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b190bef4867b9cfc6d5929c5618a6e4e
https://doi.org/10.1093/rheumatology/keh475
https://doi.org/10.1093/rheumatology/keh475
Autor:
H. Sörensen, J Brandt, Xenofon Baraliakos, Hildrun Haibel, Joachim Listing, J. Braun, Martin Rudwaleit, J. Sieper
Publikováno v:
Arthritis & Rheumatism. 53:856-863
Objective To examine the long-term outcome of patients with active ankylosing spondylitis (AS) clinically and by magnetic resonance imaging (MRI) after continuous treatment with the tumor necrosis factor (TNF) receptor fusion protein etanercept over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6924e9520f4bafefca3a1126570dc96
https://doi.org/10.1002/art.21588
https://doi.org/10.1002/art.21588
Autor:
Erika Gromnica-Ihle, Joachim Listing, Gerd-Rüdiger Burmester, Rieke Alten, A. Zink, Joachim Sieper, H Sörensen, J. Brandt, Jaqueline Reddig, Herbert Kellner, Henning Zeidler, Matthias Schneider, Jürgen Braun, W. Golder
Publikováno v:
Arthritis & Rheumatism. 48:2224-2233
Objective Treatment of ankylosing spondylitis (AS) with infliximab, an anti–tumor necrosis factor α monoclonal antibody, was shown to be efficacious in patients with active disease during a 3-month treatment period. The purpose of this study was t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef6380fd1e3e3d921340a46ef559b947
https://doi.org/10.1002/art.11104
https://doi.org/10.1002/art.11104